Gastrointestinal health is our cornerstone and the core of designing a wellness pathway for your patients.
That’s why Designs for Health focus is to develop science-based GI gut health mapping tools, leading-edge products, education and product protocols for healthcare practitioners and their patients.
The GI-MAP™ (GI-Microbial Assay Plus) test is the first comprehensive stool analysis to include an FDA-approved DNA/PCR assay for GI pathogens performed on stool*. The pathogen targets include bacteria, parasites, and another first for the market – viruses. Using the same molecular technology, for microbe assays that are useful for integrative and functional medicine practitioners. And unlike previous PCR (polymerase chain reaction) assays, we have fully validated each target organism in our panel, so that you can have confidence in the results. GI-MAP™ tests for GI pathogens, opportunistic organisms, normal flora, and markers of GI health including:
To make this information easily accessible, we’ve structured it below in an accordion-style format. Simply click on the main sections to explore the markers within. For instance, under the “Pathogens” section, you will find specific markers such as Clostridia, each linked to relevant research articles.
This layout allows practitioners to quickly locate and review the scientific studies that validate each marker, ensuring that your interpretations and recommendations are backed by the latest research.
We hope this resource enhances your practice by providing reliable, evidence-based information at your fingertips.
Other available stool tests may appear to be DNA-based, but they are, in fact, only using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) to identify stool microbes. Their methodology relies on cultures from the stool and is not molecular/PCR-based assays. With a culture-based test, it is not possible to measure strict anaerobes, viruses, or virulence factors. They also lack the ability to deliver true quantitation of any of the reported organisms.
In addition, other recent test offerings using an FDA-cleared molecular technology only for pathogens do not extend any molecular methodology over an entire comprehensive stool analysis to include opportunistic and beneficial organisms, including bacteria, protozoa, and fungi, all of which are provided through the GI-MAP™.
Many advances in DNA technology have occurred over the last ten years, including an FDA-approved PCR-based technology and assay used by major hospital labs. Considering these advances, why would you still rely on culture and microscopy for stool analysis and assessment of the GI environment?
Welcome to our comprehensive section on technical markers and references, specifically designed to help practitioners understand the research that underpins the GI-Map test report.
This section provides in-depth research data on each marker, organised to correlate with the main sections of the GI-Map test report. Research articles for each marker offer a scientific foundation for the test results.
To make this information easily accessible, we’ve structured it in an accordion-style format. Click on the main sections to explore the markers within. For instance, under the “Pathogens” section, specific markers, such as Clostridia, are each linked to relevant research articles.
This layout lets practitioners quickly locate and review the scientific studies that validate each marker, ensuring that your interpretations and recommendations are backed by the latest research.